2 months ago
BMY
AnalystsRajesh KumarRajesh Kumar's Stock Forecasts
AnalystsRajesh Kumar
Analyst Ranking
Top 28%
#1562 out of 5556 analysts
Average Return
+4.58%
Win Rate
55%17 out of 31
Risk vs Reward
Poor
Good
Rajesh Kumar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Eli Lilly & CoLLY | +111.01% | $449.46 | $948.40 | 2023-07-14 - 2024-07-12 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +106.12% | $10.13 | $20.88 | 2023-12-18 - 2024-12-17 | Strong Buy |
Regeneron Pharmaceuticals IncREGN | +39.17% | $649.81 | $904.35 | 2026-07-06 - 2026-11-06 | Strong Buy |
Abbvie IncABBV | +29.37% | $225.18 | $291.31 | 2025-12-10 - 2026-11-06 | Strong Buy |
Danaher CorpDHR | +29.30% | $178.08 | $230.25 | 2026-06-03 - 2026-11-06 | Strong Buy |
Rajesh Kumar Analyst Color
Get additional color on Rajesh Kumar's coverage of popular stocks
2 months ago
LLY
8 months ago
LLY
a year ago
NVO
a year ago
LLY
2 years ago
LLY
2 years ago
KDP
3 years ago
PFE
3 years ago
LLY
Rajesh Kumar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Novartis AgNVS | 1 | Hold | $136.00 | -16.33% | Upgrades | 2 months ago |
Abbvie IncABBV | 6 | Strong Buy | $315.00 | +8.13% | Maintains | 2 months ago |
Biogen IncBIIB | 3 | Sell | $175.00 | -29.53% | Maintains | 2 months ago |
Bristol Myers Squibb CoBMY | 4 | Hold | $65.00 | +4.60% | Maintains | 2 months ago |
Eli Lilly & CoLLY | 5 | Sell | $940.00 | -30.58% | Maintains | 2 months ago |
Johnson & JohnsonJNJ | 1 | Strong Buy | $320.00 | +15.85% | Maintains | 2 months ago |
Merck & Co IncMRK | 2 | Strong Buy | $172.00 | +17.22% | Maintains | 2 months ago |
Pfizer IncPFE | 4 | Hold | $30.00 | +2.08% | Maintains | 2 months ago |
Regeneron Pharmaceuticals IncREGN | 2 | Strong Buy | $920.00 | +1.73% | Maintains | 2 months ago |
Zoetis IncZTS | 1 | Strong Buy | $95.00 | +19.65% | Maintains | 4 months ago |
Danaher CorpDHR | 3 | Strong Buy | $230.00 | -0.11% | Maintains | 5 months ago |
Novo Nordisk A SNVO | 3 | Hold | N/A | N/A | Downgrades | a year ago |
Iqvia Holdings IncIQV | 2 | Strong Buy | $235.00 | N/A | Upgrades | a year ago |
Keurig Dr Pepper IncKDP | 1 | Strong Buy | $42.00 | N/A | Upgrades | 2 years ago |
Thermo Fisher Scientific IncTMO | 3 | Strong Buy | $670.00 | N/A | Maintains | 3 years ago |
Unitedhealth Group IncUNH | 2 | Hold | $460.00 | N/A | Upgrades | 3 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Strong Buy | $13.00 | N/A | Initiates Coverage On | 3 years ago |
Moderna IncMRNA | 1 | Sell | $97.00 | N/A | Initiates Coverage On | 3 years ago |
Biontech SeBNTX | 1 | Strong Buy | $124.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.